JPRN-UMIN000036576已完成未知
Exploring liver fibrosis biomarkers in non-alcoholic fatty liver disease (NAFLD) - Exploring liver fibrosis biomarkers in non-alcoholic fatty liver disease (NAFLD)
ippon Medical School Chiba Hokusoh Hospital0 个研究点目标入组 200 人开始时间: 2019年4月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Exclusion criteria included 1) daily alcohol consumption >30 g for males and >20 g for females; 2) other chronic liver diseases, such as viral hepatitis B or C, autoimmune hepatitis, Wilson disease, and hemochromatosis; 3) secondary causes of steatosis, such as drug-induced fatty liver disease, total parenteral nutrition, and inborn errors of metabolism.
研究者
相似试验
招募中
Unknown
Exploratory study of biomarkers for liver fibrosis assessment using non-invasive samplesonalcoholic Fatty Liver DiseaseJPRN-UMIN000050863Chugai Pharmaceutical Co., Ltd.50
已完成
不适用
Screening for Liver Fibrosis by Using Non-invasive Methods in Patients With Diabetes. A Prospective StudyDiabetesNCT01306110Association HGE CHU Bordeaux Sud277
已完成
不适用
on-invasive quantification of liver fibrosis with ultrasound: pilotliver fibrosisliver scarring10019654NL-OMON37760niversitair Medisch Centrum Groningen50
招募中
不适用
Rapid Breath-hold Quantitative Macromolecular Proton Fraction Imaging for Liver FibrosisLiver FibrosisNCT04429100Chinese University of Hong Kong200
已完成
不适用
Performances Evaluation of New FibroScan Probes Dedicated to Morbidly Obese PatientsObesity, MorbidLiver FibrosisNCT03872024Echosens180